Commencement of Operations at the New Pharmaceutical Manufacturing Building at Alfresa Pharma Corporation's Gunma Plant
NQ Score
76/100
N1 Content Completeness
9
AI Summary (NQ-processed)
Alfresa Pharma has started operations at a new manufacturing building in its Gunma plant. It strengthens low-molecular drug production and fully enters contract manufacturing for highly active and sterile formulations.
AI Analysis
Frequently Asked Questions
- Q: What does the new manufacturing building of Alfessa Pharma manufacture?
- A: In addition to low molecular weight drugs, it manufactures high pharmacological activity formulations, and conducts inspections, packaging, and testing of sterile formulations.
- Q: What is TSCS (Total Supply Chain Service)?
- A: It is a service provided by the Alfessa Group that supports the entire process from drug development and manufacturing to logistics, sales, and post-market surveillance.
- Q: What kind of service is PATH-Solution?
- A: It is a platform that removes barriers for emerging biotech companies from overseas when entering the Japanese market and provides comprehensive support.